Opexa Announces Encouraging Clinical Data on Novel T-Cell ...
PharmaLive.com (press release) - Newtown,PA,USA
The Company's lead product, Tovaxin(TM), a T-cell therapy for multiple sclerosis is in Phase IIb trials. The Company holds the exclusive worldwide license ...